comparemela.com

Latest Breaking News On - Alembic pharma q2 results - Page 1 : comparemela.com

Alembic Pharma Q2 Results: Firm posts Rs 137-crore net profit

Revenues grew 8% to Rs.1595 crore in Q2FY24 compared to Rs 1475 crore last year. The earnings before interest, tax, depreciation and amortization (EBITA) declined 6% YoY to Rs 218 crore. The EBITDA margins stood at 14% in Q2FY24.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.